Lægemiddelindustriforeningen

What Lægemiddelindustriforeningen does

Lægemiddelindustriforeningen (Lif) is the Danish trade association for the researching pharmaceutical industry, representing 39 member companies including Novo Nordisk, Lundbeck, LEO Pharma, and multinational subsidiaries such as AstraZeneca, Roche, Pfizer, and Johnson & Johnson. Founded as a membership organization (forening) and headquartered at Lersø Parkallé 101 in Copenhagen Ø, Lif operates with 51-100 employees to provide unified policy advocacy, market access support, and industry coordination on pharmaceutical regulation, pricing, and clinical research conditions in Denmark and the EU. The association's revenue model is based on membership fees from its 39 member companies; no public pricing for membership is disclosed.

Lif's core offerings center on three proprietary analytical tools. The Medicinrådstracker monitors the Danish Medicines Council's (Medicinrådet) processing of new drug assessments and recommendations, including processing times for standard treatments, cancer drugs, and rare disease therapies. The Medicintilskudsmåler tracks the Danish Medicines Agency's (Lægemiddelstyrelsen) processing of subsidy applications, decision rates, and rejection reasons. The BIS-modellen is a health economic calculator that estimates derived socioeconomic effects of pharmaceutical interventions. Lif also publishes Magasinet med., an annual industry magazine providing in-depth analysis of pharmaceutical and life science topics.

Lif's go-to-market is non-commercial: rather than selling products, the association delivers value through direct member services, policy advocacy to Danish ministries and parliament, conference organization, and multi-channel public communications (website, newsletter, LinkedIn, Twitter, Facebook, press releases). Lif participates in EFPIA's European-level Europe's Choice campaign and coordinates with adjacent associations including DANSK BIOTEK, ENLI (ethical compliance), Danish Regions, the Danish Medical Association, and international federation IFPMA.

Name

Lægemiddelindustriforeningen

Legal name

Lægemiddelindustriforeningen

Website

https://lif.dk

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Lægemiddelindustriforeningen (Lif) is the Danish trade association representing 39 researching pharmaceutical companies, providing policy advocacy, market access support, and analytical tools (Medicinrådstracker, Medicintilskudsmåler, BIS-modellen) to members including Novo Nordisk, Lundbeck, and LEO Pharma.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Trade Association

NAICS

Management Consulting Services (54161)

SIC

Services-Management Services (8741)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Pharmaceutical industry association
• Policy advocacy services
• Regulatory monitoring tools
• Health economic analysis
• Industry trade representation

Headquarters

HQ city

Copenhagen

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Distribution channels1 record

Marketing channels7 records

Core offering

Lægemiddelindustriforeningen (Lif) is the Danish trade association for the researching pharmaceutical industry. It represents 39 member companies through policy advocacy, market access support, ethical standards and industry analysis, and operates dedicated monitoring tools (Medicinrådstracker, Medicintilskudsmåler, BIS-modellen) that track regulatory and reimbursement decisions affecting member companies.

Product overview

Lif (Lægemiddelindustriforeningen) is the Danish Association of the Pharmaceutical Industry, a trade association for the researching pharmaceutical industry that works to ensure optimal conditions for pharmaceutical companies to develop, market, distribute, and provide information on medicinal products. Rather than offering a unified software platform, Lif provides a portfolio of analytical and informational tools including the Medicinrådstracker (for monitoring drug assessment decisions and processing times), the Medicintilskudsmåler (for tracking subsidy application processing), the BIS-modellen (for calculating health economic effects), and the Magasinet med. publication. These tools serve Lif's membership, policy advocacy, and public communication functions as a trade organization.

Differentiator

Problem solved

Functional benefit

Products and services

• Medicinrådstracker An analytical tracker tool that monitors the Danish Medicines Council's (Medicinrådet) processing of new drug assessments, including recommendations for standard treatments, cancer drugs, and rare disease treatments, as well as processing times.
• Medicintilskudsmåler A monitoring tool that tracks the Danish Medicines Agency's (Lægemiddelstyrelsen) processing of subsidy applications, providing current statistics on subsidy decisions, allocation rates, and processing times.
• BIS-modellen A health economic model that calculates derived health economic effects, enabling assessment of downstream impacts of pharmaceutical interventions.
• Magasinet med. A magazine publication that provides perspective on current topics relevant to the pharmaceutical industry and society broadly.

Quantifiable outcome

• Danish pharmaceutical industry exports 189 billion DKK in 2025, accounting for 19.4% of total Danish merchandise exports
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered major, core and minor.

• PACT & PhaseVmajorGTM or Marketing Partner · 1 January 2025Co-hosting conference on decentralized clinical trials titled 'Decentrale kliniske forsøg i det virkelige liv – vejen fra vision til praksis' (August 25).
• Trial NationmajorGTM or Marketing Partner · 1 January 2025Co-hosting conference on decentralized clinical trials with PACT, PhaseV and Trial Nation. Trial Nation is Denmark's network for clinical trials.
• EFPIA (European Federation of Pharmaceutical Industries and Associations)coreStrategic or Co-development PartnerLif is a member of EFPIA, the European federation representing the pharmaceutical industry. Through EFPIA, Lif participates in European pharmaceutical policy discussions, the Europe's Choice campaign (#WeWontRest), and benefits from continental industry coordination. EFPIA represents 36 national associations, 40 leading pharmaceutical companies, and numerous SMEs.
• EFPIA (Europe's Choice Campaign)coreGTM or Marketing PartnerLif participates in EFPIA's Europe's Choice campaign to advocate for investment in innovative medicines across Europe. The campaign addresses pharmaceutical policy, pricing, and access issues. Campaign currently active in multiple countries.
• ENLI (Ethical Committee for the Pharmaceutical Industry)coreStrategic or Co-development PartnerENLI enforces ethical rules and transparency requirements for collaboration between the pharmaceutical industry and healthcare stakeholders, including collaboration with regions. Lif directs members to ENLI for ethical compliance matters.
• DANSK BIOTEKmajorStrategic or Co-development PartnerLif collaborates with DANSK BIOTEK (Danish Biotechnology Association) on industry analysis, particularly joint reports on clinical trials in Denmark. Released a 2025 report showing decline in clinical trials.
• Danish Regions (Danske Regioner)majorStrategic or Co-development PartnerLif collaborates with Danish Regions on healthcare policy, including co-hosting innovation conferences. Danish Regions established Medicinrådet which Lif monitors through its tracker tools.
• Danish Medical Association (Lægeforeningen)minorGTM or Marketing PartnerCo-hosting innovation conference with Danske Regioner, IDA, Dansk Sygeplejeråd (DSR) and Lif on August 31 in Copenhagen.
• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations)coreStrategic or Co-development PartnerLif is linked to IFPMA as an international industry federation, providing global pharmaceutical industry coordination.
• McKinsey Global InstituteminorOthersReference to McKinsey report 'Prioritizing health: A prescription for prosperity' (2020) estimating €10 trillion could be added to European GDP through health investments, with 4x return on health investment.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Farmaindustria: Spanish trade association representing the research-based pharmaceutical industry; same dues-funded model, same advocacy scope (pricing, market access, regulatory cooperation).
• LEEM (Les Entreprises du Médicament): French pharmaceutical industry trade association; directly comparable national-body peer focused on industrial policy, market access negotiations and ethical standards for its members.
• VFA (Verband der forschenden Pharma-Unternehmen): German research-based pharmaceutical industry association; the largest European national peer with the same model — dues-funded advocacy for member pharma companies on market access, clinical research, and regulation.
• ABPI (Association of the British Pharmaceutical Industry): UK trade association for the researching pharmaceutical industry; structurally analogous national-body peer with comparable membership-funded policy advocacy and codes of practice.

Regional players

• Medicines Australia: Australian pharma-industry association; equivalent national advocacy and market access role with a similar analytical-tools and codes-of-conduct portfolio.
• JPMA (Japan Pharmaceutical Manufacturers Association): Japanese pharma-industry trade association; directly comparable national-body model with same member-funded policy and code-of-conduct remit, but operating in a different regulatory/geographic market.
• SwissPharm (Intergenerika / scienceindustries pharma members): Swiss pharma-industry association within scienceindustries; structural counterpart in a small, export-oriented pharma economy — directly comparable in scale and export-driven advocacy profile.

Broad incumbents

• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations): Global pharma-industry federation of which Lif is an affiliate; analogous advocacy function but at international scope — a peer/parent in the same association chain.
• PhRMA (Pharmaceutical Research and Manufacturers of America): US pharmaceutical industry trade association; same advocacy function but at far greater scale and US regulatory context — useful comparator for maturity of member services and analytical tool monetization.
• EFPIA (European Federation of Pharmaceutical Industries and Associations): Umbrella European pharma-industry association in which Lif is a member; directly comparable mandate on pharmaceutical regulatory cooperation and policy advocacy, but operating at continental scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/LifDK
• Facebookfacebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.lif.dk%2F
• LinkedInlinkedin.com/company/lifdk

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lægemiddelindustriforeningen